Related Experiment Video
Updated: Jul 27, 2025

09:14
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
11.0K
In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease
Melina Awar1, Eleftherios Mylonakis1
1Houston Methodist Hospital, Houston, Texas, USA (M.A., E.M.).
Annals of Internal Medicine
|June 5, 2023
Abstract
Source Citation:
Falsey AR, Williams K, Gymnopoulou E, et al; CYPRESS Investigators. Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609-620. 36791161.

